# Long-term Study Evaluating the Effect of Givinostat in Patients With Chronic Myeloproliferative Neoplasms

> **NCT01761968** · PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **Italfarmaco** · enrollment: 90 (estimated)

## Conditions studied

- Chronic Myeloproliferative Neoplasms

## Interventions

- **DRUG:** givinostat

## Key facts

- **NCT ID:** NCT01761968
- **Lead sponsor:** Italfarmaco
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2013-03
- **Primary completion:** 2026-12
- **Final completion:** 2026-12
- **Target enrollment:** 90 (ESTIMATED)
- **Last updated:** 2025-04-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01761968

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01761968, "Long-term Study Evaluating the Effect of Givinostat in Patients With Chronic Myeloproliferative Neoplasms". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT01761968. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*